Susan Groshen
Affiliations: | University of Southern California, Los Angeles, CA, United States |
Area:
Statistics, Biostatistics BiologyGoogle:
"Susan Groshen"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Dorff TB, Quinn DI, Pinski JK, et al. (2019) Randomized Phase II Trial of Abiraterone Alone or With Dasatinib in Men With Metastatic Castration-resistant Prostate Cancer (mCRPC). Clinical Genitourinary Cancer |
| Kraus RD, Barsky A, Ji L, et al. (2019) The Perineural Invasion Paradox: Is Perineural Invasion an Independent Prognostic Indicator of Biochemical Recurrence Risk in Patients With pT2N0R0 Prostate Cancer? A Multi-Institutional Study. Advances in Radiation Oncology. 4: 96-102 |
| Ballas LK, Luo C, Chung E, et al. (2018) Phase I trial of SBRT to the prostate fossa following prostatectomy. International Journal of Radiation Oncology, Biology, Physics |
| Brunette LL, Mhawech-Fauceglia PY, Ji L, et al. (2018) Validity and prognostic significance of sperm protein 17 as a tumor biomarker for epithelial ovarian cancer: a retrospective study. Bmc Cancer. 18: 970 |
| Ballas LK, Kraus R, Ji L, et al. (2018) Active Surveillance for Prostate Cancer: Are We Failing Latino Patients at a Large Safety Net Hospital? Clinical Genitourinary Cancer |
| Loh JM, Tran AL, Ji L, et al. (2017) Baseline Glomerular Filtration Rate and Cisplatin- Induced Renal Toxicity in Urothelial Cancer Patients. Clinical Genitourinary Cancer |
| Erdreich-Epstein A, Singh AR, Joshi S, et al. (2017) Association of high microvessel αvβ3 and low PTEN with poor outcome in stage 3 neuroblastoma: rationale for using first in class dual PI3K/BRD4 inhibitor, SF1126. Oncotarget. 8: 52193-52210 |
| Yu SS, Athreya K, Liu SV, et al. (2017) A Phase II Trial of AEZS-108 in Castration- and Taxane-Resistant Prostate Cancer. Clinical Genitourinary Cancer |
| Marachelian A, Villablanca JG, Liu CW, et al. (2017) Expression of Five Neuroblastoma Genes in Bone Marrow or Blood of Patients with Relapsed/Refractory Neuroblastoma Provides a New Biomarker for Disease and Prognosis. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Mohrbacher A, Yang AS, Groshen S, et al. (2017) Phase I Study of Fenretinide Delivered Intravenously in Patients with Relapsed or Refractory Hematologic Malignancies: a California Cancer Consortium Trial. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |